SYNTHESIS OF C-NOR-4,6-SECOCAMPTOTHECIN AND RELATED-COMPOUNDS

被引:5
作者
KURIHARA, T
TANNO, H
TAKEMURA, S
HARUSAWA, S
YONEDA, R
机构
[1] Osaka University of Pharmaceutical Sciences, Osaka, 580
关键词
D O I
10.1002/jhet.5570300311
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
C-nor-4,6-Secocamptothecin 2, 4-ethyl-4-hydroxy-6-(2-quinolinyl)-1H-pyrano[3,4-c]pyridine-3,8(4H,7H)-dione, lacking the C-ring of camptothecin 1, and its related compounds 3 and 4 were prepared from ethyl quinoline-2-carboxylate 7. By an analogous reaction sequences, synthesis of 6-(2-pyridinyl)-1H-pyrano[3,4-c]-pyridine-3,8(4H,7H)-dione derivatives 5 and 6, which contain the B, D, and E ring of 1, were achieved.
引用
收藏
页码:643 / 652
页数:10
相关论文
共 16 条
[1]   REACTIONS WITH INDOLE-DERIVATIVES .17. BIOGENETICALLY ORIENTATED TOTAL-SYNTHESIS OF DL-CAMPTOTHECIN AND 7-CHLOROCAMPTOTHECIN [J].
BOCH, M ;
WINTERFELDT, E ;
NELKE, JM ;
RADUNZ, H ;
PIKE, D ;
KORTH, T .
CHEMISCHE BERICHTE-RECUEIL, 1972, 105 (07) :2126-+
[2]  
Cai J-C., 1983, ALKALOIDS CHEM PHARM, VVol. 21, P101
[3]   SYNTHESIS AND BIOLOGICAL EVALUATION OF DE-AB-CAMPTOTHECIN [J].
DANISHEF.S ;
ETHEREDG.SJ .
JOURNAL OF ORGANIC CHEMISTRY, 1974, 39 (23) :3430-3432
[4]  
GRAS JL, 1990, ORG SYNTH, V7, P332
[5]  
HELBLING AM, 1976, HELV CHIM ACTA, V59, P938
[6]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF ALPHA-METHYLENE-GAMMA-BUTYROLACTONES [J].
HOFFMANN, HMR ;
RABE, J .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1985, 24 (02) :94-110
[7]  
KANO S, 1979, CHEM PHARM BULL, V27, P2450
[8]   SYNTHESIS OF WATER-SOLUBLE (AMINOALKYL)CAMPTOTHECIN ANALOGS - INHIBITION OF TOPOISOMERASE-I AND ANTITUMOR-ACTIVITY [J].
KINGSBURY, WD ;
BOEHM, JC ;
JAKAS, DR ;
HOLDEN, KG ;
HECHT, SM ;
GALLAGHER, G ;
CARANFA, MJ ;
MCCABE, FL ;
FAUCETTE, LF ;
JOHNSON, RK ;
HERTZBERG, RP .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) :98-107
[9]   REACTIONS WITH INDOLE-DERIVATIVES .28. ALKYLATION OF CAMPTOTHECIN-INTERMEDIATES - NEW APPROACH TO CAMPTOTHECIN [J].
KROHN, K ;
WINTERFELDT, E .
CHEMISCHE BERICHTE-RECUEIL, 1975, 108 (09) :3030-3042
[10]   BIOACTIVATION AS A MODEL FOR DRUG DESIGN BIOREDUCTIVE ALKYLATION [J].
MOORE, HW .
SCIENCE, 1977, 197 (4303) :527-532